Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.37B |
| 2 |
Microsoft
MSFT
|
+$783M |
| 3 |
Tesla
TSLA
|
+$434M |
| 4 |
UnitedHealth
UNH
|
+$402M |
| 5 |
Home Depot
HD
|
+$310M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$387M |
| 2 |
EOG Resources
EOG
|
+$370M |
| 3 |
Intel
INTC
|
+$355M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$265M |
| 5 |
Constellation Brands
STZ
|
+$260M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.67% |
| 2 | Healthcare | 15.75% |
| 3 | Financials | 12.03% |
| 4 | Consumer Discretionary | 11.76% |
| 5 | Industrials | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Columbia Sportswear
COLM
$3.19B
| $98.3K | ﹤0.01% |
1,068
-435
| -29% | -$35K |
|
1477
nCino
NCNO
$1.81B
| $98.3K | ﹤0.01% |
3,645
| – | – |
|
|
AVID
1478
DELISTED
Avid Technology Inc
AVID
| $98.2K | ﹤0.01% |
3,458
-442
| -11% | -$11.6K |
|
1479
Travel + Leisure Co
TNL
$4.54B
| $97.8K | ﹤0.01% |
2,452
-884
| -26% | -$33.1K |
|
1480
TechTarget
TTGT
$246M
| $97.8K | ﹤0.01% |
2,126
+718
| +51% | +$37.6K |
|
1481
HighPeak Energy
HPK
$967M
| $97.1K | ﹤0.01% |
4,049
+1,304
| +48% | +$29.3K |
|
1482
Lifestance Health
LFST
$4.16B
| $97.1K | ﹤0.01% |
19,076
-1,051
| -5% | -$6.5K |
|
1483
Vanguard S&P 500 Value ETF
VOOV
$6.58B
| $96.2K | ﹤0.01% |
655
| – | – |
|
|
DSEY
1484
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
| $95.2K | ﹤0.01% |
+18,890
| New | +$92.5K |
|
1485
Twist Bioscience
TWST
$5.62B
| $94.9K | ﹤0.01% |
3,550
+830
| +31% | +$24.1K |
|
1486
Stratasys
SSYS
$697M
| $94.5K | ﹤0.01% |
6,921
+1,393
| +25% | +$18.6K |
|
|
IAS
1487
DELISTED
Integral Ad Science
IAS
| $93.9K | ﹤0.01% |
+9,758
| New | +$82.8K |
|
|
CLVR
1488
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
| $93.7K | ﹤0.01% |
8,444
| – | – |
|
1489
Pacific Biosciences
PACB
$422M
| $92.9K | ﹤0.01% |
9,399
-8,704
| -48% | -$75K |
|
1490
Zentalis Pharmaceuticals
ZNTL
$308M
| $92.7K | ﹤0.01% |
4,389
-363
| -8% | -$7.81K |
|
1491
Live Oak Bancshares
LOB
$1.95B
| $92.5K | ﹤0.01% |
+2,911
| New | +$92.9K |
|
1492
Magnite
MGNI
$2.65B
| $92.4K | ﹤0.01% |
8,739
+1,249
| +17% | +$11.4K |
|
1493
SkinHealth Systems
SKIN
$94.9M
| $91.7K | ﹤0.01% |
9,032
+1,754
| +24% | +$18.9K |
|
1494
NeoGenomics
NEO
$1.81B
| $91K | ﹤0.01% |
8,662
-3,023
| -26% | -$28.2K |
|
1495
ReNew
RNW
$2.24B
| $90.4K | ﹤0.01% |
15,996
+5,550
| +53% | +$32.4K |
|
1496
Digital Turbine
APPS
$1.02B
| $89K | ﹤0.01% |
5,317
+1,327
| +33% | +$20.4K |
|
|
DICE
1497
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $88.3K | ﹤0.01% |
+2,993
| New | +$97.6K |
|
1498
Veracyte
VCYT
$4.52B
| $88.3K | ﹤0.01% |
+3,500
| New | +$81.3K |
|
1499
UiPath
PATH
$5.62B
| $88.3K | ﹤0.01% |
6,671
-4,730
| -41% | -$58.5K |
|
1500
Vanguard S&P 500 Growth ETF
VOOG
$25.4B
| $87.2K | ﹤0.01% |
2,430
| – | – |
|
Similar funds
Amundi's Q4 2022 Portfolio in Review
As of Q4 2022, Amundi held 2,034 positions worth $182B, up 8.1% from $169B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Amundi's Q4 2022 filing shows 182 new, 779 increased, 651 reduced and 138 closed positions. Its largest new stake was Atlassian: 508,372 shares worth $72.1M. The largest sale was Cigna, an estimated $387M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Amundi's largest Q4 2022 buy was Atlassian: 508,372 shares worth $72.1M.
- Amundi added most to Amazon in Q4 2022, an estimated $1.37B increase.
- Amundi's biggest Q4 2022 reduction was Cigna, cutting an estimated $387M.
- Amundi fully exited Twitter, Inc. in Q4 2022, selling an estimated $194M.
- Amundi's ten largest holdings make up 18% of its $182B portfolio in Q4 2022.
- Amundi opened 182 new positions and closed 138 in Q4 2022.
- Amundi's portfolio value rose 8.1% quarter-over-quarter to $182B.
Based on Amundi's 13F filing for Q4 2022, filed 14 Feb 2023.